Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03359850
Title Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90033 United States Details
GSK Investigational Site Newport Beach California 92663 United States Details
GSK Investigational Site Aurora Colorado 80045 United States Details
GSK Investigational Site Atlanta Georgia 30322 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field